Trademark Overview
On Thursday, November 28, 2024, a trademark application was filed for PIJOIMI with the United States Patent and Trademark Office. The USPTO has given the PIJOIMI trademark a serial number of 79415254. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, January 23, 2025. This trademark is owned by Merck Kommanditgesellschaft auf Aktien. The PIJOIMI trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceuticals, namely preparations for the treatment of cardiovascular, diabetic, dermatological, endocrinological, gastroenterological, genetic, hormonal, infectious, immunological, inflammatory, metabolic, musculoskeletal, neurological, oncological, ophthalmic, psychiatric, pulmonary, reproductive health, respiratory, rheumatological, thyroid diseases and disorders, and viral infections